Mankind Pharma Limited
SBI Mutual Fund is no longer listed among Mankind Pharma Limited’s key shareholders this quarter. Previously holding a 1.55 percent stake, SBI Mutual Fund has either fully exited or trimmed its position below the 1 percent disclosure threshold.
A pharmaceutical company that develops, manufactures, and markets a diverse range of formulations across acute and chronic therapeutic areas alongside consumer healthcare products. Incorporated in 1995, the company operates through multiple distribution channels and disease segments within India's pharmaceutical market. Its portfolio spans prescription medicines, over-the-counter products, and wellness offerings designed to serve diverse patient populations and healthcare needs.
India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.